Atul Saran
Director/Board Member bij Emergent Countermeasures International Ltd.
Vermogen: 219 212 $ op 31-03-2024
Profiel
Atul Saran is currently the Director at Emergent Product Development UK Ltd., Secretary & Director at Emergent Countermeasures International Ltd., and a Member at The District of Columbia Bar.
He previously worked as a Director at Inotek Pharmaceuticals Corp.
and Arriva Pharmaceuticals, Inc. He was also an Independent Director at Xencor, Inc. from 2011 to 2014, a Director at VentiRx Pharmaceuticals, Inc., and the Vice President-Corporate Development & Ventures at MedImmune LLC from 2003 to 2014.
He was also the Vice President-Corporate Development & Ventures at AstraZeneca PLC from 2013 to 2014, and the SVP-Corporate Development & Ventures at MedImmune Ventures, Inc. He served as the Senior Vice President & General Counsel at MacroGenics, Inc. from 2014 to 2017.
He is currently the Executive VP, Chief Strategy & Development Officer at Emergent BioSolutions, Inc. from 2017 to 2023.
He was also an Associate Attorney at Hogan & Hartson LLP.
Mr. Saran received his undergraduate degree from Stanford University, his MBA from MIT Sloan School of Management, and his graduate degree from the University of Illinois College of Law.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
28-02-2023 | 86 645 ( 0.17% ) | 219 212 $ | 31-03-2024 |
Actieve functies van Atul Saran
Bedrijven | Functie | Begin |
---|---|---|
The District of Columbia Bar
The District of Columbia Bar Miscellaneous Commercial ServicesCommercial Services The District of Columbia Bar provides legal services. The private company is based in Washington. | Corporate Officer/Principal | - |
Emergent Product Development UK Ltd.
Emergent Product Development UK Ltd. Pharmaceuticals: MajorHealth Technology Emergent Product Development (UK) Ltd. develops oral vaccines for typhoid, traveler's diarrhea, hepatitis B, and anthrax. It also develops vaccines for meningitis and another for streptococcal infections for infants. The company is a biotechnology company focused on harnessing the immune system to treat and prevent disease in areas of significant unmet clinical needs. It was founded in 1996 and is located in Wokingham, UK. | Director/Board Member | 20-12-2017 |
Emergent Countermeasures International Ltd.
Emergent Countermeasures International Ltd. Pharmaceuticals: MajorHealth Technology Founded in 2015, Emergent Countermeasures International Ltd. is a British pharmaceutical company that manufactures pharmaceutical preparations. Part of Emergent BioSolutions, Inc., the private company is based in Richmond, UK. | Director/Board Member | 18-12-2018 |
Eerdere bekende functies van Atul Saran
Bedrijven | Functie | Einde |
---|---|---|
EMERGENT BIOSOLUTIONS INC. | General Counsel | 01-03-2022 |
MACROGENICS, INC. | General Counsel | 01-05-2017 |
California State Bar Association | Corporate Officer/Principal | 15-05-2014 |
XENCOR, INC. | Director/Board Member | 23-01-2014 |
ASTRAZENECA PLC | Corporate Officer/Principal | 01-01-2014 |
Opleiding van Atul Saran
Stanford University | Undergraduate Degree |
MIT Sloan School of Management | Masters Business Admin |
University of Illinois College of Law | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 4 |
---|---|
ASTRAZENECA PLC | Health Technology |
XENCOR, INC. | Health Technology |
MACROGENICS, INC. | Health Technology |
EMERGENT BIOSOLUTIONS INC. | Health Technology |
Bedrijven in privébezit | 10 |
---|---|
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
Inotek Pharmaceuticals Corp.
Inotek Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Inotek Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company. It focuses on the discovery, development and commercialization of therapies for glaucoma and other diseases of the eye. The company's product candidate includes Trabodenoson, an adenosine mimetic that has completed Phase II clinical trials for lowering IOP by restoring the eye's natural pressure control mechanism. It is also developing Trabodenoson plus Latanoprost, a prostaglandin analogue that has completed Phase II clinical trials for use in patients with inadequate responses to treatment with latanoprost; and Trabodenoson monotherapy for the treatment of optic nerve neuropathy. Inotek Pharmaceuticals was founded on July 7, 1999 by Csaba Szabo and Andrew L. Salzman and is headquartered in Lexington, MA. | Health Technology |
Arriva Pharmaceuticals, Inc.
Arriva Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arriva Pharmaceuticals is a privately held biopharmaceutical company focused on developing anti-inflammatory therapies for treating respiratory diseases. The company's areas of therapeutic focus are: hereditary emphysema, Chronic Obstructive Pulmonary Disease (COPD) including smoking-related emphysema, cystic fibrosis and other respiratory indications. Arriva’s current clinical focus is the development of Respriva™, its nebulized, recombinant alpha 1-antitrypsin for hereditary emphysema. Arriva Pharmaceuticals, Inc., is located in Alameda, California. | Health Technology |
MedImmune Ventures, Inc.
MedImmune Ventures, Inc. Investment ManagersFinance MedImmune Ventures, Inc. ( Medimmune Ventures) is a venture capital firm founded in 2002 by Ron Laufer, Wayne Hockmeyer and David Mott . The firm is headquartered in Gaithersburg, Maryland. | Finance |
VentiRx Pharmaceuticals, Inc.
VentiRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology VentiRx Pharmaceuticals, Inc. develops and commercializes novel medicines for the treatment of cancer, respiratory, and inflammatory diseases. It focuses on the development of novel small molecule product candidates targeting toll-like receptor 8 for applications in oncology, allergy, autoimmune, and inflammatory diseases. The company was founded by Michael J. Kamdar and Robert Hershberg on June 12, 2006 and is headquartered in Seattle, WA. | Health Technology |
Hogan & Hartson LLP
Hogan & Hartson LLP Miscellaneous Commercial ServicesCommercial Services Hogan & Hartson LLP provides legal services. Its is specialized in areas include energy, government contracts, immigration, and litigation. The company has offices in across Asia, Europe, Latin America and North America. Hogan & Hartston was founded in 1904 and is headquartered in Washington, DC. | Commercial Services |
Emergent Product Development UK Ltd.
Emergent Product Development UK Ltd. Pharmaceuticals: MajorHealth Technology Emergent Product Development (UK) Ltd. develops oral vaccines for typhoid, traveler's diarrhea, hepatitis B, and anthrax. It also develops vaccines for meningitis and another for streptococcal infections for infants. The company is a biotechnology company focused on harnessing the immune system to treat and prevent disease in areas of significant unmet clinical needs. It was founded in 1996 and is located in Wokingham, UK. | Health Technology |
The District of Columbia Bar
The District of Columbia Bar Miscellaneous Commercial ServicesCommercial Services The District of Columbia Bar provides legal services. The private company is based in Washington. | Commercial Services |
California State Bar Association | |
Emergent Countermeasures International Ltd.
Emergent Countermeasures International Ltd. Pharmaceuticals: MajorHealth Technology Founded in 2015, Emergent Countermeasures International Ltd. is a British pharmaceutical company that manufactures pharmaceutical preparations. Part of Emergent BioSolutions, Inc., the private company is based in Richmond, UK. | Health Technology |